Stuart Poulton Karyopharm Therapeutics Inc. (KPTI) insider trading activity
Stuart Poulton is EVP, Chief Development Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 27,414 shares of KPTI, which is worth approximately $132,957. The most recent transaction as insider was on Mar 04, 2025, when has been sold 3,548 shares (Common Stock) at a price of $6.29 per share, resulting in proceeds of $22,316. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
27.4K
91.61%
3M change
91.68%
12M change
Total Value Held
$132,957
Stuart Poulton Transaction History
SP
Stuart Poulton
EVP, Chief Development Officer
Newton, MA